Irinotecan is a cytostatic – a drug that inhibits cell growth and cell division. It also suppresses the function of the immune system to reduce the occurrence of inflammation (immunosuppressant). Irinotecan is a topoisomerase inhibitor.
Irinotecan is prescribed to treat cancer of the large intestine and rectum, if the cancer has reached an advanced stage. It is also used to treat lung cancer and pancreatic cancer.
Irinotecan and the benefit of DNA analysis
The rate at which irinotecan is processed within your body varies from one individual to another. This means that the efficacy and side effects of irinotecan can be predicted to some extent on the basis of your genes.
Preventive DNA analysis can therefore be an important tool in optimising your medication.
Also known as
onivyde